MicroRNA-21 Knockout Improve the Survival Rate in DSS Induced Fatal Colitis through Protecting against Inflammation and Tissue Injury

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Shi, Chenzhang ^a   Liang, Yong ^a   Yang, Jun ^a   Xia, Yang ^a   Chen, Hongqi ^a   Han, Huazhong ^a   Yang, Yongzhi ^a   Wu, Wen ^a   Gao, Renyuan ^a   Qin, Huanlong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD68 ANTIGEN; CYCLIN D1; DEXTRAN SULFATE; HEMOGLOBIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; MICRORNA 21; PROTEIN CDC42; RHOB GUANINE NUCLEOTIDE BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; COLITIS; COLON INJURY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DISEASE SEVERITY; EPITHELIUM CELL; ERYTHROCYTE COUNT; FATALITY; GENE DELETION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INACTIVATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENOTYPE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN VIVO STUDY; INFLAMMATORY INFILTRATE; INTESTINE MUCOSA PERMEABILITY; INTESTINE OBSTRUCTION; KNOCKOUT MOUSE; LEUKOCYTE COUNT; MOUSE; NONHUMAN; SURVIVAL RATE; SURVIVAL TIME; TRANSGENIC MOUSE; ULCERATIVE COLITIS; UPREGULATION; WEIGHT REDUCTION; WILD TYPE;

ANIMALS; APOPTOSIS; COLITIS; CYTOKINES; DEXTRAN SULFATE; DISEASE SUSCEPTIBILITY; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; INFLAMMATION; INTESTINAL MUCOSA; INTESTINES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; PERMEABILITY; SURVIVAL ANALYSIS;

MURINAE; MUS;

EID: 84879476666     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066814     Document Type: Article

References (43)

1. Hatley ME, Patrick DM, Garcia MR, Richardson JA, Bassel-Duby R, et al. (2010) Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell 18: 282-293.
2. Medina PP, Nolde M, Slack FJ, (2010) OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 467: 86-90.
3. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, et al. (2008) MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456: 980-984.
4. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, et al. (2008) MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27: 2128-2136.
5. Zhu S, Wu H, Wu F, Nie D, Sheng S, et al. (2008) MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 18: 350-359.
6. Wu F, Zikusoka M, Trindade A, Dassopoulos T, Harris ML, et al. (2008) MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology 135: 1624-1635 e1624.
7. Takagi T, Naito Y, Mizushima K, Hirata I, Yagi N, et al. (2010) Increased expression of microRNA in the inflamed colonic mucosa of patients with active ulcerative colitis. J Gastroenterol Hepatol 25Suppl 1: S129-133.
8. Wu F, Zhang S, Dassopoulos T, Harris ML, Bayless TM, et al. (2010) Identification of microRNAs associated with ileal and colonic Crohn's disease. Inflamm Bowel Dis 16: 1729-1738.
9. Noble CL, Abbas AR, Cornelius J, Lees CW, Ho GT, et al. (2008) Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis. Gut 57: 1398-1405.
10. Mesko B, Poliska S, Szegedi A, Szekanecz Z, Palatka K, et al. (2010) Peripheral blood gene expression patterns discriminate among chronic inflammatory diseases and healthy controls and identify novel targets. BMC Med Genomics 3: 15.
11. Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, et al. (2003) Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52: 65-70.
12. Lu TX, Munitz A, Rothenberg ME, (2009) MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression. J Immunol 182: 4994-5002.
13. Wu H, Neilson JR, Kumar P, Manocha M, Shankar P, et al. (2007) miRNA profiling of naive, effector and memory CD8 T cells. PLoS One 2: e1020.
14. Hashimi ST, Fulcher JA, Chang MH, Gov L, Wang S, et al. (2009) MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation. Blood 114: 404-414.
15. Wu Z, Lu H, Sheng J, Li L, (2012) Inductive microRNA-21 impairs anti-mycobacterial responses by targeting IL-12 and Bcl-2. FEBS Lett 586: 2459-2467.
16. Chan JA, Krichevsky AM, Kosik KS, (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65: 6029-6033.
17. Sayed D, He M, Hong C, Gao S, Rane S, et al. (2010) MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand. J Biol Chem 285: 20281-20290.
18. Marquez RT, Wendlandt E, Galle CS, Keck K, McCaffrey AP, (2010) MicroRNA-21 is upregulated during the proliferative phase of liver regeneration, targets Pellino-1, and inhibits NF-kappaB signaling. Am J Physiol Gastrointest Liver Physiol 298: G535-541.
19. Ng R, Song G, Roll GR, Frandsen NM, Willenbring H, (2012) A microRNA-21 surge facilitates rapid cyclin D1 translation and cell cycle progression in mouse liver regeneration. J Clin Invest 122: 1097-1108.
20. Wang P, Zou F, Zhang X, Li H, Dulak A, et al. (2009) microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells. Cancer Res 69: 8157-8165.
21. Zhang X, Ng WL, Wang P, Tian L, Werner E, et al. (2012) MicroRNA-21 Modulates the Levels of Reactive Oxygen Species Levels by Targeting SOD3 and TNFα. Cancer Res 72(18): 4707-4713.
22. Nuovo GJ, (2008) In situ detection of precursor and mature microRNAs in paraffin embedded, formalin fixed tissues and cell preparations. Methods 44: 39-46.
23. Liu H, Lin H, Zhang L, Sun Q, Yuan G, et al. (2013) MiR-145 and miR-143 regulate odontoblast differentiation through targeting Klf4 and Osx in a feedback loop. J Biol Chem 288(13): 9261-9271.
24. Smith P, Mangan NE, Walsh CM, Fallon RE, McKenzie AN, et al. (2007) Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism. J Immunol 178: 4557-4566.
25. Vetrano S, Rescigno M, Cera MR, Correale C, Rumio C, et al. (2008) Unique role of junctional adhesion molecule-a in maintaining mucosal homeostasis in inflammatory bowel disease. Gastroenterology 135: 173-184.
26. Danese S, Sans M, Spencer DM, Beck I, Donate F, et al. (2007) Angiogenesis blockade as a new therapeutic approach to experimental colitis. Gut 56: 855-862.
27. Scaldaferri F, Sans M, Vetrano S, Graziani C, De Cristofaro R, et al. (2007) Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease. J Clin Invest 117: 1951-1960.
28. Krieglstein CF, Cerwinka WH, Sprague AG, Laroux FS, Grisham MB, et al. (2002) Collagen-binding integrin alpha1beta1 regulates intestinal inflammation in experimental colitis. J Clin Invest 110: 1773-1782.
29. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, et al. (2009) Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58: 1091-1103.
30. Karhausen J, Furuta GT, Tomaszewski JE, Johnson RS, Colgan SP, et al. (2004) Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J Clin Invest 114: 1098-1106.
31. Aherne CM, Collins CB, Masterson JC, Tizzano M, Boyle TA, et al. (2012) Neuronal guidance molecule netrin-1 attenuates inflammatory cell trafficking during acute experimental colitis. Gut 61(5): 695-705.
32. Spencer DM, Veldman GM, Banerjee S, Willis J, Levine AD, (2002) Distinct inflammatory mechanisms mediate early versus late colitis in mice. Gastroenterology 122: 94-105.
33. Schaefer JS, Montufar-Solis D, Vigneswaran N, Klein JR, (2011) Selective upregulation of microRNA expression in peripheral blood leukocytes in IL-10-/- mice precedes expression in the colon. J Immunol 187: 5834-5841.
34. Han X, Ren X, Jurickova I, Groschwitz K, Pasternak BA, et al. (2009) Regulation of intestinal barrier function by signal transducer and activator of transcription 5b. Gut 58: 49-58.
35. Sheedy FJ, Palsson-McDermott E, Hennessy EJ, Martin C, O'Leary JJ, et al. (2010) Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol 11: 141-147.
36. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ, (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res 36: D154-158.
37. Etienne-Manneville S, Hall A, (2003) Cdc42 regulates GSK-3beta and adenomatous polyposis coli to control cell polarity. Nature 421: 753-756.
38. Etienne-Manneville S, (2004) Cdc42-the centre of polarity. J Cell Sci 117: 1291-1300.
39. Sakamori R, Das S, Yu S, Feng S, Stypulkowski E, et al. (2012) Cdc42 and Rab8a are critical for intestinal stem cell division, survival, and differentiation in mice. J Clin Invest 122: 1052-1065.
40. Muller AJ, Hoffmann C, Galle M, Van Den Broeke A, Heikenwalder M, et al. (2009) The S. Typhimurium effector SopE induces caspase-1 activation in stromal cells to initiate gut inflammation. Cell Host Microbe 6: 125-136.
41. Flamant M, Aubert P, Rolli-Derkinderen M, Bourreille A, Neunlist MR, et al. (2011) Enteric glia protect against Shigella flexneri invasion in intestinal epithelial cells: a role for S-nitrosoglutathione. Gut 60: 473-484.
42. Krause-Gruszczynska M, Boehm M, Rohde M, Tegtmeyer N, Takahashi S, et al. (2011) The signaling pathway of Campylobacter jejuni-induced Cdc42 activation: Role of fibronectin, integrin beta1, tyrosine kinases and guanine exchange factor Vav2. Cell Commun Signal 9: 32.
43. Yang Y, Ma Y, Shi C, Chen H, Zhang H, et al. (2013) Overexpression of miR-21 in patients with ulcerative colitis impairs intestinal epithelial barrier function through targeting the Rho GTPase RhoB. Biochem Biophys Res Commun 434(4): 746-752.